Ribosomal Protein L23
Overview
Ribosomal Protein L23 (RPL23) is a highly conserved structural and catalytic component of the large ribosomal subunit (60S in eukaryotes, 50S in prokaryotes). This protein is encoded by the RPL23 gene located on chromosome 5p13 in humans, with orthologs present across all domains of life. RPL23 comprises approximately 144 amino acids and has a molecular weight of approximately 16 kDa. As part of the ribosomal RNA (rRNA)-binding protein complex, RPL23 occupies a strategic position at the peptidyl transferase center interface, making it integral to the fundamental process of protein synthesis. The protein has emerged as a relevant factor in neurodegeneration research due to its connection with stress responses and its involvement in ribosomal dysfunction observed in several neurodegenerative diseases.
Function/Biology
RPL23 functions as a structural scaffold protein and catalytic contributor within the large ribosomal subunit. The protein establishes multiple contact points with 28S rRNA, particularly within the peptidyl transferase center region, which is the catalytic heart of the ribosome where peptide bonds form between amino acids. RPL23 also interacts with other ribosomal proteins including RPL22 and several components of the exit tunnel, which guides nascent polypeptide chains through the ribosome.
...Ribosomal Protein L23
Overview
Ribosomal Protein L23 (RPL23) is a highly conserved structural and catalytic component of the large ribosomal subunit (60S in eukaryotes, 50S in prokaryotes). This protein is encoded by the RPL23 gene located on chromosome 5p13 in humans, with orthologs present across all domains of life. RPL23 comprises approximately 144 amino acids and has a molecular weight of approximately 16 kDa. As part of the ribosomal RNA (rRNA)-binding protein complex, RPL23 occupies a strategic position at the peptidyl transferase center interface, making it integral to the fundamental process of protein synthesis. The protein has emerged as a relevant factor in neurodegeneration research due to its connection with stress responses and its involvement in ribosomal dysfunction observed in several neurodegenerative diseases.
Function/Biology
RPL23 functions as a structural scaffold protein and catalytic contributor within the large ribosomal subunit. The protein establishes multiple contact points with 28S rRNA, particularly within the peptidyl transferase center region, which is the catalytic heart of the ribosome where peptide bonds form between amino acids. RPL23 also interacts with other ribosomal proteins including RPL22 and several components of the exit tunnel, which guides nascent polypeptide chains through the ribosome.
In addition to its canonical ribosomal function, RPL23 exhibits extraribosomal activities. The protein translocates to the nucleus under certain stress conditions and has been identified in association with ribosomal biogenesis pathways. RPL23 participates in the assembly and maturation of pre-ribosomal complexes through interactions with assembly factors and processing machinery. The protein also exhibits stress-responsive properties, with evidence suggesting dynamic modification and relocalization patterns during cellular stress conditions including oxidative stress, which is particularly relevant to neuronal cells with high metabolic demand.
Role in Neurodegeneration
RPL23 dysfunction has been implicated in multiple neurodegenerative disease contexts. In Parkinson's disease, alterations in ribosomal protein composition, including RPL23 expression changes, have been documented in substantia nigra tissue and in cellular models of dopaminergic neurodegeneration. The protein's role in protein synthesis fidelity becomes particularly critical in neurons, where accumulation of misfolded proteins—a hallmark of neurodegenerative diseases—can trigger proteostatic collapse.
In Alzheimer's disease research, ribosomal protein dysregulation, including RPL23 alterations, has been associated with translation defects and reduced synthesis of critical neuroprotective proteins. Ribosomal dysfunction contributes to impaired translation of mRNAs encoding synaptic proteins necessary for cognitive function. Additionally, RPL23 has been investigated in the context of amyotrophic lateral sclerosis (ALS), where motor neuron-specific protein synthesis demands are exceptionally high, making ribosomal integrity particularly relevant.
Molecular Mechanisms
The neurodegenerative mechanisms involving RPL23 operate through several interconnected pathways. Impaired ribosomal function leads to reduced translation efficiency and accuracy, compromising the synthesis of neuroprotective proteins including antioxidant enzymes, chaperone proteins, and synaptic components. This proteostatic stress activates cellular stress responses including the unfolded protein response (UPR), which chronically triggers pro-apoptotic pathways in vulnerable neurons.
RPL23 mutations or expression dysregulation can compromise the structural integrity of the 60S subunit, leading to ribosomal stalling and triggering no-go decay pathways that degrade aberrant transcripts. In stressed neurons, dysregulated RPL23 may fail to maintain optimal translation fidelity, permitting synthesis of partially misfolded protein variants that seed aggregation cascades. Furthermore, oxidative damage to RPL23 itself, through carbonylation or cross-linking, can impair ribosomal function without requiring genetic alterations.
Clinical/Research Significance
RPL23 represents a therapeutic target emerging from systems-level analyses of neurodegeneration. Proteomic studies of postmortem neurodegenerative disease brain tissue and transcriptomic profiling of disease-affected neurons consistently identify ribosomal protein alterations. Understanding RPL23-dependent mechanisms may illuminate why neurons are particularly vulnerable to proteostatic dysfunction and suggests that stabilizing ribosomal protein composition could represent neuroprotective strategy.
Research into RPL23 also informs understanding of how systemic ribosomal dysfunction contributes to neuronal specificity in diseases affecting multiple tissues, and how cell-type-specific vulnerabilities emerge from differential proteostatic demands.
- Ribosomal RNA (rRNA) and 60S large subunit assembly
- Ribosomal protein L22 and L24 (interacting partners)
- Unfolded protein response (UPR) pathways
- Protein synthesis and translation fidelity
- Parkinsonian neurodegeneration
- Alzheimer's disease proteostasis dysfunction
- Amyotrophic lateral sclerosis motor neuron pathology